Clene’s FDA update; JCR ends ties with Takeda, partners with AstraZeneca; Gilead ups stake in Hookipa

Plus, news on Lyndra Therapeutics, Hadean Capital, Barinthus Bio, Shattuck Labs and Inventiva.

Clene Nanomedicine’s roadblock: The company, which is developing a gold nanocrystal-based drug to treat ALS called CNM-Au8, met with the FDA to discuss the possibility of an accelerated approval using biomarker data for neurofilament light chain —…
Click here to view original post